StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
203450.KQ$2670.00-3.58%
Fair $2670.00+0.0%

203450.KQ

UNION biometrics Co., Ltd.

Unknown / UnknownKOSDAQ

$2670.00

-100.00 (-3.58%)

Fairly Valued+0.0%Fair Value $2670.00Fund rank 28/100 · Data gapFallback financials|
SA 29/D
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $7.8B · quality 49.0/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

29/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 4.8%, below the 5% threshold
Thesis & Journal · 203450.KQLocal privado en este navegador · UNION biometrics Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$32.0B

P/E

16.0x

↑

EV/EBITDA

12.4x

↑

ROE

4.8%

↑

Gross Margin

37.5%

↑

Debt/Equity

0.21

↑
52-Week Range$2670
$2630$4230

TradingView lightweight chart

203450.KQ price, volumen y niveles de valoración

Último $2,690Periodo -20.9%
Fair value: $2,670

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+3.5%

FCF CAGR

—

FCF margin

-24.7%

FCF / Net income

-6.30x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $51.32B · net income $2.01B · FCF $-12.67B

2022-FY → 2025-FY

Gross margin

37.5%+3.5% pts

Operating margin

2.0%-0.9% pts

Net margin

3.9%-0.7% pts

FCF margin

-24.7%-18.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$51.32B$51.32B$56.75B$51.38B$46.25B
Net Income$2.01B$2.01B$4.95B$3.07B$2.16B
EBITDA$2.70B$2.70B$6.39B$3.99B$3.26B
EPS167.00167.00398.00238.00166.00
Gross Margin37.5%37.5%35.2%34.3%34.0%
Operating Margin2.0%2.0%5.0%3.1%2.9%
Net Margin3.9%3.9%8.7%6.0%4.7%
Balance Sheet
Debt/Equity0.210.210.200.210.23
Cash Flow
Free Cash Flow$-12.67B$-12.67B$10.52B$7.81B$-2.69B
Returns
ROE4.8%4.8%11.8%7.7%5.8%
Valuation
P/E15.9915.996.8613.7418.83
EV/EBITDA12.4012.403.199.8713.50
P/B0.770.770.811.061.10
Growth & Yield
Revenue Growth-9.6%-9.6%10.4%11.1%—
EPS Growth-58.0%-58.0%67.2%43.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

12.4%

razonable

EPS terminal req.

$236.92

Spread vs growth

-70.4%

5Y implied EPS CAGR

11.4%

razonable

EPS terminal req.

$286.67

Spread vs growth

-69.5%

10Y implied EPS CAGR

10.7%

razonable

EPS terminal req.

$461.69

Spread vs growth

-68.7%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -11.2%

Total return

-11.2%

Start / end P/E

7.6x → 16.1x

EPS bridge

398.00 → 167.00

Residual

-64.8%

EPS growth-58.0%
Multiple rerating+111.6%
Dividend+0.0%
Residual / FX / buybacks / cross-term-64.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.